• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    Pluristem Therapeutics, Inc. (PSTI)

    -NasdaqCM
    2.81 Down 0.06(2.09%) Apr 17, 3:58PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.0
    Mean Recommendation (last week):2.0
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:5.50
    Median Target:5.00
    High Target:8.00
    Low Target:4.00
    No. of Brokers:4

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 8, 2014H.C. WainwrightInitiated Buy
    Sep 16, 2013Maxim GroupUpgradeHoldBuy
    Jun 4, 2013Maxim GroupDowngradeBuyHold
    May 31, 2013MLV & CoInitiated Buy
    Nov 19, 2012Brinson PatrickInitiated Market Outperform
    Jul 25, 2012Maxim GroupInitiated Buy
    Jul 24, 2012WBB SecuritiesDowngradeSpeculative BuyHold
    May 22, 2012NeedhamInitiated Buy
    Dec 9, 2011Global Hunter SecuritiesInitiated Speculative Buy
    Jun 17, 2011Dawson JamesInitiated Buy

    More Upgrades & Downgrades for PSTI

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0000
    Buy0433
    Hold0011
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.